Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism
Authors
Keywords
-
Journal
Nanomedicine
Volume 10, Issue 7, Pages 1127-1138
Publisher
Future Medicine Ltd
Online
2015-05-01
DOI
10.2217/nnm.14.165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes
- (2013) Huajun Jin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Resveratrol: New Avenues for a Natural Compound in Neuroprotection
- (2013) Mercè Pallàs et al. CURRENT PHARMACEUTICAL DESIGN
- Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases
- (2013) Albino Carrizzo et al. FOOD AND CHEMICAL TOXICOLOGY
- The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease
- (2013) Li Zuo et al. GENE
- Lipid-Core Nanocapsules Improve the Effects of Resveratrol Against Aβ-Induced Neuroinflammation
- (2013) Rudimar L. Frozza et al. Journal of Biomedical Nanotechnology
- Neuroprotective Effects of Resveratrol Against Aβ Administration in Rats are Improved by Lipid-Core Nanocapsules
- (2013) Rudimar L. Frozza et al. MOLECULAR NEUROBIOLOGY
- Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
- (2012) Filipe C. Matheus et al. BEHAVIOURAL BRAIN RESEARCH
- Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease
- (2012) Adalberto A. Castro et al. BEHAVIOURAL BRAIN RESEARCH
- Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries
- (2012) V. Foti Cuzzola et al. CNS & Neurological Disorders-Drug Targets
- Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats
- (2012) Najeh Maissar Khalil et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Olfactory dysfunction in Parkinson disease
- (2012) Richard L. Doty Nature Reviews Neurology
- The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinson's disease
- (2011) Rui D. S. Prediger et al. CURRENT PHARMACEUTICAL DESIGN
- Administration of resveratrol: What formulation solutions to bioavailability limitations?
- (2011) A. Amri et al. JOURNAL OF CONTROLLED RELEASE
- Transport of drugs across the blood–brain barrier by nanoparticles
- (2011) Stefanie Wohlfart et al. JOURNAL OF CONTROLLED RELEASE
- Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease
- (2010) Mohd.Moshahid Khan et al. BRAIN RESEARCH
- Intranasal delivery of zidovudine by PLA and PLA–PEG blend nanoparticles
- (2010) Rubiana Mara Mainardes et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson’s disease
- (2010) Eduardo L. G. Moreira et al. JOURNAL OF NEURAL TRANSMISSION
- Risk is in the Air
- (2009) Rui D. S. Prediger et al. Annals of the New York Academy of Sciences
- Improvements of cellular stress response on resveratrol in liposomes
- (2009) Julijana Kristl et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters
- (2009) Svetlana Gelperina et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by α-synuclein or amyloid-β (1-42) peptide
- (2009) Diego Albani et al. JOURNAL OF NEUROCHEMISTRY
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease
- (2009) Rui D. S. Prediger et al. NEUROTOXICITY RESEARCH
- Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
- (2008) Feng Jin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Complexation of resveratrol with cyclodextrins: Solubility and antioxidant activity
- (2008) Zhong Lu et al. FOOD CHEMISTRY
- Neuroprotective Effects of Resveratrol on MPTP-Induced Neuron Loss Mediated by Free Radical Scavenging
- (2008) Kwok-Tung Lu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Neurobiology and treatment of Parkinson's disease
- (2008) Anthony H.V. Schapira TRENDS IN PHARMACOLOGICAL SCIENCES
- Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
- (2008) Claire Henchcliffe et al. Nature clinical practice. Neurology
- Disease-modifying drugs and Parkinson's disease
- (2007) Hervé Allain et al. PROGRESS IN NEUROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started